AMRX(Amneal Pharmaceuticals, Inc.) · 财务报表

AMRX(Amneal Pharmaceuticals, Inc.) 的财务报表:医疗保健,特药与仿制药。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$2.09B$2.21B$2.39B$2.79B$3.02B
毛利润$768.97M$784.71M$820.57M$1.02B$1.11B
营业利润$152.72M−$94.93M$204.37M$249.33M$394.10M
净利润$13.16M−$270.58M−$83.99M−$116.89M$72.06M
经营现金流$241.82M$65.10M$345.58M$295.10M$339.99M
自由现金流$194.09M$18.69M$302.36M$243.18M$269.93M
摊薄每股收益$0.07$-0.86$-0.48$-0.38$0.22

Amneal Pharmaceuticals, Inc. AMRX